Researchers have found a way to decode the brain activity associated with individual abstract scientific concepts pertaining to matter and energy, such as fermion or dark matter.

The Society for Neuroscience’s (SfN) flagship conference, SfN 2021, has moved to an online-only offering after numerous speaker withdrawals threatened the “scientific coherence” of the event.

New research uses 3D modeling to analyse the way Deep Neural Networks – part of the broader family of machine learning – process information, to visualise how their information processing matches that of humans.

A new study led by researchers at Harvard Medical School has unveiled a mechanism that may underlie the greater sensitivity of certain skin regions.

Researchers have identified molecules in the blood that can indicate impending dementia. According to the study data, microRNAs could potentially also be targets for dementia therapy.

Ischemic stroke, the second leading cause of death worldwide, occurs when a vessel to the brain is blocked, reducing blood flow to the brain and depriving it of critical supplies of oxygen and nutrients. New research has aimed to develop an effective treatment for stroke that focuses on the use of a peptidase known as neurolysin (Nln).

New research sheds light on how the developing cerebral cortex – the outermost layer of the brain, associated with high-level processing – develops its characteristic map, which is common across human beings and critical to our functioning.

Neuroscientists have discovered a novel, non-invasive imaging-based method to investigate the visual sensory thalamus, an important structure of the human brain and point of origin of visual difficulties in diseases such as dyslexia and glaucoma. The new method could provide an in-depth understanding of visual sensory processing in both health and disease in the near future.

Our DNA is very similar to that of the chimpanzee, which in evolutionary terms is our closest living relative. Stem cell researchers have now found a previously overlooked part of our DNA, so-called non-coded DNA, that appears to contribute to a difference which, despite all our similarities, may explain why our brains work differently.

A new study conducted using mice suggests that targeting the alpha-synuclein protein may not be sufficient to treat the disease and alleviate symptoms in most patients.